Search Results

Press Releases

Visby Medical™ Receives FDA Clearance and CLIA Waiver for Point-of-Care Respiratory Health Test

February 26, 2025

·

2 min read

Press Releases

Visby Medical Secures Additional $3.9M from CARB-X to Fight Antibiotic Resistance with PCR-Based Mutation Detection at the POC

January 15, 2025

·

3 min read

Biotech Bay

Visby Medical™ Receives FDA Clearance and CLIA Waiver for Second Generation Sexual Health Test for Women

Visby Medical™ announced today that it has received 510(k) clearance and was granted a CLIA waiver from the U.S. Food and Drug Administration for its second generation point of care (POC) test.

March 14, 2023

·

4 min read

FDA

Visby Medical™ Receives FDA Emergency Use Authorization for Respiratory Health Test for use in CLIA waived settings

Visby Medical™ announced today that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration for its Respiratory Health point of care test.

January 3, 2023

·

3 min read

Business

Visby Medical Appoints Everett Cunningham to Board of Directors

Visby Medical™, a leading medical diagnostic company, announced Everett Cunningham has been appointed to the company’s Board of Directors.

May 25, 2022

·

2 min read

Biotech Bay

Visby Medical Expands Series E Round to Over $135 Million

Visby Medical™, a leading medical diagnostic company, announced that it expanded its over-subscribed Series E financing round to include an additional $35 million for a total of over $135 million raised in the round.

June 29, 2022

·

3 min read

Biotech Bay

Visby Medical Raises over $100 Million in Series E Financing

Visby Medical™, a leading medical diagnostic company, announced that it has raised over $100 million in its Series E financing round, with investment led by Ping An Voyager Partners and joined by the Healthcare of Ontario Pension Plan.

March 1, 2022

·

3 min read

Business

Visby Medical Appoints Terri S. Bresenham and Scott Edward Mendel to Board of Directors

Visby Medical, a leading medical diagnostic company, today announced Terri Bresenham and Scott Mendel have been appointed to the company’s Board of Directors.

January 4, 2022

·

3 min read

Biotech Bay

The American Association for Clinical Chemistry Announces Visby Medical’s Handheld PCR Diagnostic Platform as 2022 Disruptive Technology Award Finalist

The American Association for Clinical Chemistry announced Wednesday that they have selected Visby Medical as a finalist for the 2022 Disruptive Technology Award for its handheld point-of-care PCR diagnostic technology.

June 15, 2022

·

2 min read

Biotech Bay

Visby Medical to Present at the J.P. Morgan 40th Annual Healthcare Conference

Visby Medical™, a leading medical diagnostic company, today announced that it will make its debut appearance at the 40th Annual J.P. Morgan Healthcare Conference.

January 10, 2022

·

1 min read